We are live on ! Find out more
VCYT icon

Veracyte

149 hedge funds and large institutions have $983M invested in Veracyte in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 54 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

218% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 11

112% more capital invested

Capital invested by funds: $465M → $983M (+$519M)

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

19% more funds holding

Funds holding: 125149 (+24)

4.44% more ownership

Funds ownership: 91.17%95.61% (+4.4%)

19% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 54

43% less call options, than puts

Call options by funds: $1.54M | Put options by funds: $2.69M

Holders
149
Holders Change
+24
Holders Change %
+19.2%
% of All Funds
3.22%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.15%
New
35
Increased
44
Reduced
54
Closed
11
Calls
$1.54M
Puts
$2.69M
Net Calls
-$1.15M
Net Calls Change
-$894K

VCYT Hedge Fund Activity: Q1 2019 in Review

149 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2019, worth a combined $983M — up 112% from $465M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new VCYT positions and 11 closed out — a net gain of 24 holders — while 44 added to existing stakes and 54 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $65.9M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $52.4M.

  • 149 institutional investors held Veracyte (VCYT) as of Q1 2019, up from 125 in Q4 2018.
  • Funds reported $983M of Veracyte stock for Q1 2019, up 112% quarter-over-quarter.
  • 35 funds opened new Veracyte positions in Q1 2019 and 11 closed out, a net change of +24 holders.
  • The largest Veracyte buyer in Q1 2019 was Gilder Gagnon Howe & Co, an estimated $65.9M added.
  • The largest Veracyte seller in Q1 2019 was TPG Group Holdings (SBS) Advisors, an estimated $52.4M sold.

Based on aggregated 13F filings for Q1 2019.